Abbvie Inc

Market cap: $287,041,807,802

Exchange: NYS

Sector: Health Technology

Share
Tweet

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Key Statistics

Company Name

Abbvie Inc

Average Volume (10 days)

5,682,928

Average Volume (30 days)

5,446,093

Moving Average (50 days)

$168.26

Moving Average (200 days)

$159.63

Ex-Divided Date

Apr 12, 2024

Dividend Yield

0.0368

P/E Ratio

48.2342

Market Cap

287,041,807,802

Shares Outstanding

1,765,867,781

52-Week High Split Adjust Only

181.2

52-Week Low Split Adjust Only

125.85

Employee Count

50,000

Beta

0.3105

Next Earnings Date

2024-07-25

TTM Dividend Rate Per Share

5.9761

Price Changes

Past 5 days

0%

Past 30 days

-0.03%

Past 3 months

-0.06%

Past 6 months

0.17%

Past year

0.14%

Past 2 years

0.15%

Past 5 years

1.62%

Max % Change

6.39%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Abbvie IncABBV3.9814.58n/a3.985.49
Peer AvgN/A4.888.9314.24.885.39
Lilly(Eli) & CoLLY7.5227.7725.27.528.03
Astrazeneca plc - ADRAZN5.4010.33n/a5.405.85
AMGEN Inc.AMGN5.4314.6514.65.436.31
Pfizer Inc.PFE4.883.1610.24.885.46
Glaxosmithkline plc - ADRGSK2.104.91n/a2.102.71
Bristol-Myers Squibb Co.BMY3.433.908.83.434.21
Gilead Sciences, Inc.GILD3.244.379.43.244.20
Biogen IncBIIB3.193.7714.63.193.57
Neurocrine Biosciences, Inc.NBIX8.707.5544.78.708.17